1 Bousser MG, Ferro JM. Cerebral venous thrombosis:anupdate[J]. Lancet Neurol, 2007, 6:162-170.2 Ferro JM, Canhao P, Stam J, et al. Prognosis ofcerebral vein and dural sinus thrombosis:results of theInternational Study on Cerebral Vein and Dural SinusThrombosis (ISCVT)[J]. Stroke, 2004, 35:664-670.3 Dentali F, Crowther M, Ageno W. Thrombophilicabnormalities, oral contraceptives, and risk of cerebral vein thrombosis:a meta-analysis[J]. Blood, 2006,107:2766-2773.4 Gosk-Bierska I, Wysokinski W, Brown RD Jr, et al.Cerebral venous sinus thrombosis:Incidence of venousthrombosis recurrence and survival[J]. Neurology,2006, 67:814-819.5 Saposnik G, Barinagarrementeria F, Brown RD Jr,et al. American Heart Association Stroke Counciland the Council on Epidemiology and Prevention.Diagnosis and management of cerebral venousthrombosis:a statement for healthcare professionalsfrom the American Heart Association/AmericanStroke Association[J]. Stroke, 2011, 42:1158-1192.6 Cundiff DK. Anticoagulants for cerebral venousthrombosis:Harmful to patients?[J]. Stroke, 2014,45:298-304.7 Gulati D, Strbian D, Sundararajan S. Cerebral venousthrombosis:Diagnosis and management[J]. Stroke,2014, 45:e16-e18. |